We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Biomarker Shows Potential for Early Detection of AMD

By LabMedica International staff writers
Posted on 03 Aug 2009
Print article
A biomarker has been discovered with strong potential for both early detection and preventive treatment of neovascular (or wet-type), age-related macular degeneration (AMD) in humans.

Called CCR3, the marker for AMD was used in animal experiments--quantum dots attached to anti-CCR3 antibodies were injected into the eyes of living mice. They bound to CCR3 on the surface of abnormal vessels making them visible through conventional means, even before they had penetrated the retina.

Neovascular macular degeneration is caused by choroidal neovascularization (CNV)--the invasive growth of new blood vessels in the thin vascular layer that provides nourishment and oxygen to the eye. Central vision loss occurs when these abnormal blood vessels invade the retina, the light-sensitive tissue that lines the inner surface of the eyeball.

CCR3 not only provides a unique genetic signature for CNV, but also it actively promotes the growth of these abnormal blood vessels in the eye. Thus, the same anti-CCR3 antibodies used to detect CNV could be useful as a clinical treatment to prevent macular degeneration.

A team, led by Dr. Jayakrishna Ambati, professor of physiology, professor and vice-chair of ophthalmology and visual sciences at the University of Kentucky (Lexington, KY, USA), discovered the biological marker CCR3A, which is associated with AMD, the leading cause of blindness in older adult men and women. The investigators discovered that CCR3--a molecule also implicated in inflammatory processes--is expressed on the surface of CNV vessels in humans but is absent from normal vascular tissue.

Dr. Ambati commented, "With CCR3, we have for the first time found a unique molecular signature for the disease. This brings us closer than we have ever been to developing a clinical diagnostic tool to discover and treat the disease early, before vision is lost."

The Kentucky University team's work was published in the June 14, 2009 edition of Nature.

Related Links:

University of Kentucky
Nature


New
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Unit-Dose Packaging solution
HLX
New
Sexually Transmitted Diseases Test
STD Panel Strip
New
Respiratory Syncytial Virus Test
QuickVue RSV Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate Arc System has been granted US FDA 510(k) clearance (Photo courtesy of Accelerate Diagnostics)

Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR

Delayed administration of antibiotics to patients with bloodstream infections significantly increases the risk of morbidity and mortality. For optimal therapeutic outcomes, it is crucial to rapidly identify... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.